Your browser doesn't support javascript.
loading
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia.
Roboz, Gail J; Kantarjian, Hagop M; Yee, Karen W L; Kropf, Patricia L; O'Connell, Casey L; Griffiths, Elizabeth A; Stock, Wendy; Daver, Naval G; Jabbour, Elias; Ritchie, Ellen K; Walsh, Katherine J; Rizzieri, David; Lunin, Scott D; Curio, Tania; Chung, Woonbok; Hao, Yong; Lowder, James N; Azab, Mohammad; Issa, Jean-Pierre J.
Afiliación
  • Roboz GJ; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York.
  • Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yee KWL; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kropf PL; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • O'Connell CL; Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Griffiths EA; Roswell Park Cancer Institute, Buffalo, New York.
  • Stock W; University of Chicago, Chicago, Illinois.
  • Daver NG; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ritchie EK; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York.
  • Walsh KJ; Ohio State University, Columbus, Ohio.
  • Rizzieri D; Duke University Medical Center, Durham, North Carolina.
  • Lunin SD; Florida Cancer Specialist and Research Institute, Fort Myers, Florida.
  • Curio T; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York.
  • Chung W; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania.
  • Hao Y; Astex Pharmaceuticals, Pleasanton, California.
  • Lowder JN; Astex Pharmaceuticals, Pleasanton, California.
  • Azab M; Astex Pharmaceuticals, Pleasanton, California.
  • Issa JJ; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania.
Cancer ; 124(2): 325-334, 2018 01 15.
Article en En | MEDLINE | ID: mdl-29211308

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article